BioSyent Inc. (BIOYF) Stock Competitors & Peer Comparison
See (BIOYF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BIOYF | $9.82 | -1.50% | 112.3M | 17.54 | $0.56 | +1.55% |
| MKKGY | $32.06 | +1.33% | 69.7B | 23.76 | $1.35 | +1.61% |
| MKGAF | $156.15 | -2.23% | 67.9B | 23.10 | $6.76 | +1.65% |
| IPSEY | $46.75 | +3.80% | 61.8B | 30.36 | $1.54 | +0.99% |
| TKPHF | $31.30 | +2.72% | 49.4B | 41.73 | $0.75 | +4.17% |
| HLNCF | $4.46 | +3.72% | 39.5B | 17.84 | $0.25 | +2.15% |
| TEVJF | $30.34 | +0.50% | 35.3B | 22.64 | $1.34 | N/A |
| SDZNY | $81.26 | +0.22% | 35.2B | 38.92 | $2.09 | +1.25% |
| TAIPY | $14.00 | +16.67% | 18.1B | 82.35 | $0.17 | N/A |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
Stock Comparison
BIOYF vs MKKGY Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, MKKGY has a market cap of 69.7B. Regarding current trading prices, BIOYF is priced at $9.82, while MKKGY trades at $32.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas MKKGY's P/E ratio is 23.76. In terms of profitability, BIOYF's ROE is +0.22%, compared to MKKGY's ROE of +0.09%. Regarding short-term risk, BIOYF is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check MKKGY's competition here
BIOYF vs MKGAF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, MKGAF has a market cap of 67.9B. Regarding current trading prices, BIOYF is priced at $9.82, while MKGAF trades at $156.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas MKGAF's P/E ratio is 23.10. In terms of profitability, BIOYF's ROE is +0.22%, compared to MKGAF's ROE of +0.08%. Regarding short-term risk, BIOYF is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check MKGAF's competition here
BIOYF vs IPSEY Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, IPSEY has a market cap of 61.8B. Regarding current trading prices, BIOYF is priced at $9.82, while IPSEY trades at $46.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas IPSEY's P/E ratio is 30.36. In terms of profitability, BIOYF's ROE is +0.22%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, BIOYF is less volatile compared to IPSEY. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check IPSEY's competition here
BIOYF vs TKPHF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, TKPHF has a market cap of 49.4B. Regarding current trading prices, BIOYF is priced at $9.82, while TKPHF trades at $31.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas TKPHF's P/E ratio is 41.73. In terms of profitability, BIOYF's ROE is +0.22%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, BIOYF is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check TKPHF's competition here
BIOYF vs HLNCF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, HLNCF has a market cap of 39.5B. Regarding current trading prices, BIOYF is priced at $9.82, while HLNCF trades at $4.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas HLNCF's P/E ratio is 17.84. In terms of profitability, BIOYF's ROE is +0.22%, compared to HLNCF's ROE of +0.06%. Regarding short-term risk, BIOYF is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check HLNCF's competition here
BIOYF vs TEVJF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, TEVJF has a market cap of 35.3B. Regarding current trading prices, BIOYF is priced at $9.82, while TEVJF trades at $30.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas TEVJF's P/E ratio is 22.64. In terms of profitability, BIOYF's ROE is +0.22%, compared to TEVJF's ROE of +0.21%. Regarding short-term risk, BIOYF is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check TEVJF's competition here
BIOYF vs SDZNY Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, SDZNY has a market cap of 35.2B. Regarding current trading prices, BIOYF is priced at $9.82, while SDZNY trades at $81.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas SDZNY's P/E ratio is 38.92. In terms of profitability, BIOYF's ROE is +0.22%, compared to SDZNY's ROE of +0.10%. Regarding short-term risk, BIOYF is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check SDZNY's competition here
BIOYF vs TAIPY Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, TAIPY has a market cap of 18.1B. Regarding current trading prices, BIOYF is priced at $9.82, while TAIPY trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas TAIPY's P/E ratio is 82.35. In terms of profitability, BIOYF's ROE is +0.22%, compared to TAIPY's ROE of +0.02%. Regarding short-term risk, BIOYF is less volatile compared to TAIPY. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check TAIPY's competition here
BIOYF vs ESALY Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, BIOYF is priced at $9.82, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas ESALY's P/E ratio is 20.54. In terms of profitability, BIOYF's ROE is +0.22%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, BIOYF is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check ESALY's competition here
BIOYF vs BIOVF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, BIOVF has a market cap of 16.4B. Regarding current trading prices, BIOYF is priced at $9.82, while BIOVF trades at $47.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas BIOVF's P/E ratio is 169.11. In terms of profitability, BIOYF's ROE is +0.22%, compared to BIOVF's ROE of +0.02%. Regarding short-term risk, BIOYF is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check BIOVF's competition here
BIOYF vs SGIOF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, SGIOF has a market cap of 15B. Regarding current trading prices, BIOYF is priced at $9.82, while SGIOF trades at $17.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas SGIOF's P/E ratio is 11.71. In terms of profitability, BIOYF's ROE is +0.22%, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, BIOYF is less volatile compared to SGIOF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check SGIOF's competition here
BIOYF vs SGIOY Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, SGIOY has a market cap of 14.6B. Regarding current trading prices, BIOYF is priced at $9.82, while SGIOY trades at $8.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas SGIOY's P/E ratio is 11.44. In terms of profitability, BIOYF's ROE is +0.22%, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, BIOYF is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check SGIOY's competition here
BIOYF vs IPSEF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, IPSEF has a market cap of 9.3B. Regarding current trading prices, BIOYF is priced at $9.82, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas IPSEF's P/E ratio is 18.07. In terms of profitability, BIOYF's ROE is +0.22%, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, BIOYF is more volatile compared to IPSEF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check IPSEF's competition here
BIOYF vs SFOSF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, SFOSF has a market cap of 6.9B. Regarding current trading prices, BIOYF is priced at $9.82, while SFOSF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas SFOSF's P/E ratio is 13.68. In terms of profitability, BIOYF's ROE is +0.22%, compared to SFOSF's ROE of +0.09%. Regarding short-term risk, BIOYF is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check SFOSF's competition here
BIOYF vs BCHMF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, BCHMF has a market cap of 6.8B. Regarding current trading prices, BIOYF is priced at $9.82, while BCHMF trades at $91.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas BCHMF's P/E ratio is 36.35. In terms of profitability, BIOYF's ROE is +0.22%, compared to BCHMF's ROE of +0.11%. Regarding short-term risk, BIOYF is more volatile compared to BCHMF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check BCHMF's competition here
BIOYF vs ESALF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, ESALF has a market cap of 6.7B. Regarding current trading prices, BIOYF is priced at $9.82, while ESALF trades at $23.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas ESALF's P/E ratio is 28.09. In terms of profitability, BIOYF's ROE is +0.22%, compared to ESALF's ROE of +0.04%. Regarding short-term risk, BIOYF is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check ESALF's competition here
BIOYF vs ESAIY Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, ESAIY has a market cap of 6.5B. Regarding current trading prices, BIOYF is priced at $9.82, while ESAIY trades at $5.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas ESAIY's P/E ratio is 27.48. In terms of profitability, BIOYF's ROE is +0.22%, compared to ESAIY's ROE of +0.04%. Regarding short-term risk, BIOYF is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check ESAIY's competition here
BIOYF vs GZPHF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, GZPHF has a market cap of 6.2B. Regarding current trading prices, BIOYF is priced at $9.82, while GZPHF trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, BIOYF's ROE is +0.22%, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, BIOYF is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check GZPHF's competition here
BIOYF vs HLUBF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, HLUBF has a market cap of 5.8B. Regarding current trading prices, BIOYF is priced at $9.82, while HLUBF trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas HLUBF's P/E ratio is 9.48. In terms of profitability, BIOYF's ROE is +0.22%, compared to HLUBF's ROE of +0.15%. Regarding short-term risk, BIOYF is more volatile compared to HLUBF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check HLUBF's competition here
BIOYF vs HLBBF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, HLBBF has a market cap of 5.8B. Regarding current trading prices, BIOYF is priced at $9.82, while HLBBF trades at $7.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas HLBBF's P/E ratio is 14.29. In terms of profitability, BIOYF's ROE is +0.22%, compared to HLBBF's ROE of +0.15%. Regarding short-term risk, BIOYF is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check HLBBF's competition here
BIOYF vs LVZPF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, LVZPF has a market cap of 5.1B. Regarding current trading prices, BIOYF is priced at $9.82, while LVZPF trades at $4.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas LVZPF's P/E ratio is 12.79. In terms of profitability, BIOYF's ROE is +0.22%, compared to LVZPF's ROE of +0.14%. Regarding short-term risk, BIOYF is more volatile compared to LVZPF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check LVZPF's competition here
BIOYF vs DNPUF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, DNPUF has a market cap of 4.7B. Regarding current trading prices, BIOYF is priced at $9.82, while DNPUF trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas DNPUF's P/E ratio is 6.25. In terms of profitability, BIOYF's ROE is +0.22%, compared to DNPUF's ROE of +0.42%. Regarding short-term risk, BIOYF is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check DNPUF's competition here
BIOYF vs LABFF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, BIOYF is priced at $9.82, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas LABFF's P/E ratio is 28.95. In terms of profitability, BIOYF's ROE is +0.22%, compared to LABFF's ROE of +0.21%. Regarding short-term risk, BIOYF is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check LABFF's competition here
BIOYF vs SMDPY Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, SMDPY has a market cap of 4.5B. Regarding current trading prices, BIOYF is priced at $9.82, while SMDPY trades at $9.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas SMDPY's P/E ratio is 5.92. In terms of profitability, BIOYF's ROE is +0.22%, compared to SMDPY's ROE of +0.42%. Regarding short-term risk, BIOYF is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check SMDPY's competition here
BIOYF vs SGFEF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, SGFEF has a market cap of 4.4B. Regarding current trading prices, BIOYF is priced at $9.82, while SGFEF trades at $100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas SGFEF's P/E ratio is 20.62. In terms of profitability, BIOYF's ROE is +0.22%, compared to SGFEF's ROE of +0.16%. Regarding short-term risk, BIOYF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check SGFEF's competition here
BIOYF vs HKMPY Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, HKMPY has a market cap of 4.3B. Regarding current trading prices, BIOYF is priced at $9.82, while HKMPY trades at $39.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas HKMPY's P/E ratio is 10.80. In terms of profitability, BIOYF's ROE is +0.22%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, BIOYF is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check HKMPY's competition here
BIOYF vs HKMPF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, HKMPF has a market cap of 4.1B. Regarding current trading prices, BIOYF is priced at $9.82, while HKMPF trades at $19.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas HKMPF's P/E ratio is 10.54. In terms of profitability, BIOYF's ROE is +0.22%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, BIOYF is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check HKMPF's competition here
BIOYF vs APNHY Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, APNHY has a market cap of 3.9B. Regarding current trading prices, BIOYF is priced at $9.82, while APNHY trades at $8.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas APNHY's P/E ratio is -35.08. In terms of profitability, BIOYF's ROE is +0.22%, compared to APNHY's ROE of -0.02%. Regarding short-term risk, BIOYF is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check APNHY's competition here
BIOYF vs APNHF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, APNHF has a market cap of 3.6B. Regarding current trading prices, BIOYF is priced at $9.82, while APNHF trades at $8.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas APNHF's P/E ratio is -32.80. In terms of profitability, BIOYF's ROE is +0.22%, compared to APNHF's ROE of -0.02%. Regarding short-term risk, BIOYF is more volatile compared to APNHF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check APNHF's competition here
BIOYF vs CAMRF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, CAMRF has a market cap of 3.5B. Regarding current trading prices, BIOYF is priced at $9.82, while CAMRF trades at $58.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas CAMRF's P/E ratio is 47.93. In terms of profitability, BIOYF's ROE is +0.22%, compared to CAMRF's ROE of +0.16%. Regarding short-term risk, BIOYF is less volatile compared to CAMRF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check CAMRF's competition here
BIOYF vs LBTSF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, BIOYF is priced at $9.82, while LBTSF trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas LBTSF's P/E ratio is 59.04. In terms of profitability, BIOYF's ROE is +0.22%, compared to LBTSF's ROE of +0.04%. Regarding short-term risk, BIOYF is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check LBTSF's competition here
BIOYF vs INVVY Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, BIOYF is priced at $9.82, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas INVVY's P/E ratio is -62.42. In terms of profitability, BIOYF's ROE is +0.22%, compared to INVVY's ROE of -0.42%. Regarding short-term risk, BIOYF is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check INVVY's competition here
BIOYF vs CURLF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, CURLF has a market cap of 3B. Regarding current trading prices, BIOYF is priced at $9.82, while CURLF trades at $11.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas CURLF's P/E ratio is -26.71. In terms of profitability, BIOYF's ROE is +0.22%, compared to CURLF's ROE of -0.13%. Regarding short-term risk, BIOYF is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check CURLF's competition here
BIOYF vs DMPHF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, DMPHF has a market cap of 2.9B. Regarding current trading prices, BIOYF is priced at $9.82, while DMPHF trades at $59.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas DMPHF's P/E ratio is 26.70. In terms of profitability, BIOYF's ROE is +0.22%, compared to DMPHF's ROE of +0.21%. Regarding short-term risk, BIOYF is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check DMPHF's competition here
BIOYF vs IZQVF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, BIOYF is priced at $9.82, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, BIOYF's ROE is +0.22%, compared to IZQVF's ROE of -0.99%. Regarding short-term risk, BIOYF is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check IZQVF's competition here
BIOYF vs HYPMY Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, HYPMY has a market cap of 2.9B. Regarding current trading prices, BIOYF is priced at $9.82, while HYPMY trades at $4.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas HYPMY's P/E ratio is 8.32. In terms of profitability, BIOYF's ROE is +0.22%, compared to HYPMY's ROE of +0.13%. Regarding short-term risk, BIOYF is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check HYPMY's competition here
BIOYF vs ULIHF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, ULIHF has a market cap of 2.6B. Regarding current trading prices, BIOYF is priced at $9.82, while ULIHF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas ULIHF's P/E ratio is 8.13. In terms of profitability, BIOYF's ROE is +0.22%, compared to ULIHF's ROE of +0.13%. Regarding short-term risk, BIOYF is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check ULIHF's competition here
BIOYF vs HMDCF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, HMDCF has a market cap of 2.5B. Regarding current trading prices, BIOYF is priced at $9.82, while HMDCF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas HMDCF's P/E ratio is 5.47. In terms of profitability, BIOYF's ROE is +0.22%, compared to HMDCF's ROE of +0.41%. Regarding short-term risk, BIOYF is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check HMDCF's competition here
BIOYF vs TCNNF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, TCNNF has a market cap of 2.3B. Regarding current trading prices, BIOYF is priced at $9.82, while TCNNF trades at $11.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas TCNNF's P/E ratio is -29.37. In terms of profitability, BIOYF's ROE is +0.22%, compared to TCNNF's ROE of -0.07%. Regarding short-term risk, BIOYF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check TCNNF's competition here
BIOYF vs CHSYF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, CHSYF has a market cap of 2.3B. Regarding current trading prices, BIOYF is priced at $9.82, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas CHSYF's P/E ratio is 9.31. In terms of profitability, BIOYF's ROE is +0.22%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, BIOYF is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check CHSYF's competition here
BIOYF vs NPNKF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, NPNKF has a market cap of 2.2B. Regarding current trading prices, BIOYF is priced at $9.82, while NPNKF trades at $32.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas NPNKF's P/E ratio is 11.87. In terms of profitability, BIOYF's ROE is +0.22%, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, BIOYF is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check NPNKF's competition here
BIOYF vs HTSUF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, BIOYF is priced at $9.82, while HTSUF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, BIOYF's ROE is +0.22%, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, BIOYF is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check HTSUF's competition here
BIOYF vs GTBIF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, GTBIF has a market cap of 2B. Regarding current trading prices, BIOYF is priced at $9.82, while GTBIF trades at $8.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas GTBIF's P/E ratio is 16.78. In terms of profitability, BIOYF's ROE is +0.22%, compared to GTBIF's ROE of +0.07%. Regarding short-term risk, BIOYF is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check GTBIF's competition here
BIOYF vs ARSUF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, ARSUF has a market cap of 1.9B. Regarding current trading prices, BIOYF is priced at $9.82, while ARSUF trades at $26.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas ARSUF's P/E ratio is 18.55. In terms of profitability, BIOYF's ROE is +0.22%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, BIOYF is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check ARSUF's competition here
BIOYF vs DUTV Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, BIOYF is priced at $9.82, while DUTV trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas DUTV's P/E ratio is N/A. In terms of profitability, BIOYF's ROE is +0.22%, compared to DUTV's ROE of -0.09%. Regarding short-term risk, BIOYF is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check DUTV's competition here
BIOYF vs TSMRF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, TSMRF has a market cap of 1.7B. Regarding current trading prices, BIOYF is priced at $9.82, while TSMRF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas TSMRF's P/E ratio is 10.04. In terms of profitability, BIOYF's ROE is +0.22%, compared to TSMRF's ROE of +0.09%. Regarding short-term risk, BIOYF is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check TSMRF's competition here
BIOYF vs SHPHF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, SHPHF has a market cap of 1.7B. Regarding current trading prices, BIOYF is priced at $9.82, while SHPHF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas SHPHF's P/E ratio is -6.22. In terms of profitability, BIOYF's ROE is +0.22%, compared to SHPHF's ROE of +0.03%. Regarding short-term risk, BIOYF is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check SHPHF's competition here
BIOYF vs NPPNY Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, NPPNY has a market cap of 1.6B. Regarding current trading prices, BIOYF is priced at $9.82, while NPPNY trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas NPPNY's P/E ratio is 8.84. In terms of profitability, BIOYF's ROE is +0.22%, compared to NPPNY's ROE of +0.11%. Regarding short-term risk, BIOYF is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check NPPNY's competition here
BIOYF vs MITPF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, BIOYF is priced at $9.82, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas MITPF's P/E ratio is -10.81. In terms of profitability, BIOYF's ROE is +0.22%, compared to MITPF's ROE of +4.99%. Regarding short-term risk, BIOYF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check MITPF's competition here
BIOYF vs KARBF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, BIOYF is priced at $9.82, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas KARBF's P/E ratio is 262.50. In terms of profitability, BIOYF's ROE is +0.22%, compared to KARBF's ROE of N/A. Regarding short-term risk, BIOYF is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check KARBF's competition here
BIOYF vs CMOPF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, CMOPF has a market cap of 1.5B. Regarding current trading prices, BIOYF is priced at $9.82, while CMOPF trades at $88.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas CMOPF's P/E ratio is -341.10. In terms of profitability, BIOYF's ROE is +0.22%, compared to CMOPF's ROE of -0.01%. Regarding short-term risk, BIOYF is more volatile compared to CMOPF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check CMOPF's competition here
BIOYF vs CASBF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, CASBF has a market cap of 1.4B. Regarding current trading prices, BIOYF is priced at $9.82, while CASBF trades at $3.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas CASBF's P/E ratio is 198.50. In terms of profitability, BIOYF's ROE is +0.22%, compared to CASBF's ROE of -0.00%. Regarding short-term risk, BIOYF is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check CASBF's competition here
BIOYF vs CHIZF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, BIOYF is priced at $9.82, while CHIZF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas CHIZF's P/E ratio is -27.34. In terms of profitability, BIOYF's ROE is +0.22%, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, BIOYF is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check CHIZF's competition here
BIOYF vs SWGHF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, BIOYF is priced at $9.82, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, BIOYF's ROE is +0.22%, compared to SWGHF's ROE of +0.06%. Regarding short-term risk, BIOYF is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check SWGHF's competition here
BIOYF vs TWAPF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, TWAPF has a market cap of 1.2B. Regarding current trading prices, BIOYF is priced at $9.82, while TWAPF trades at $25.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas TWAPF's P/E ratio is 9.45. In terms of profitability, BIOYF's ROE is +0.22%, compared to TWAPF's ROE of +0.03%. Regarding short-term risk, BIOYF is more volatile compared to TWAPF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check TWAPF's competition here
BIOYF vs EVOTF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, EVOTF has a market cap of 1.2B. Regarding current trading prices, BIOYF is priced at $9.82, while EVOTF trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas EVOTF's P/E ratio is -5.27. In terms of profitability, BIOYF's ROE is +0.22%, compared to EVOTF's ROE of -0.25%. Regarding short-term risk, BIOYF is more volatile compared to EVOTF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check EVOTF's competition here
BIOYF vs LJUIF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, BIOYF is priced at $9.82, while LJUIF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, BIOYF's ROE is +0.22%, compared to LJUIF's ROE of +0.06%. Regarding short-term risk, BIOYF is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check LJUIF's competition here
BIOYF vs BIOGY Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, BIOYF is priced at $9.82, while BIOGY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, BIOYF's ROE is +0.22%, compared to BIOGY's ROE of +0.26%. Regarding short-term risk, BIOYF is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check BIOGY's competition here
BIOYF vs KSPHF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, BIOYF is priced at $9.82, while KSPHF trades at $25.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas KSPHF's P/E ratio is 12.45. In terms of profitability, BIOYF's ROE is +0.22%, compared to KSPHF's ROE of +0.06%. Regarding short-term risk, BIOYF is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check KSPHF's competition here
BIOYF vs SHEZF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, SHEZF has a market cap of 1.1B. Regarding current trading prices, BIOYF is priced at $9.82, while SHEZF trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas SHEZF's P/E ratio is -36.03. In terms of profitability, BIOYF's ROE is +0.22%, compared to SHEZF's ROE of +0.03%. Regarding short-term risk, BIOYF is more volatile compared to SHEZF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check SHEZF's competition here
BIOYF vs GLASF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, GLASF has a market cap of 1B. Regarding current trading prices, BIOYF is priced at $9.82, while GLASF trades at $13.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas GLASF's P/E ratio is -20.00. In terms of profitability, BIOYF's ROE is +0.22%, compared to GLASF's ROE of -0.26%. Regarding short-term risk, BIOYF is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check GLASF's competition here
BIOYF vs KKPCF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, BIOYF is priced at $9.82, while KKPCF trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas KKPCF's P/E ratio is 297.56. In terms of profitability, BIOYF's ROE is +0.22%, compared to KKPCF's ROE of +0.01%. Regarding short-term risk, BIOYF is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check KKPCF's competition here
BIOYF vs GNMLF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, GNMLF has a market cap of 928.9M. Regarding current trading prices, BIOYF is priced at $9.82, while GNMLF trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas GNMLF's P/E ratio is 10.56. In terms of profitability, BIOYF's ROE is +0.22%, compared to GNMLF's ROE of +0.11%. Regarding short-term risk, BIOYF is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check GNMLF's competition here
BIOYF vs CSWYF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, CSWYF has a market cap of 815.8M. Regarding current trading prices, BIOYF is priced at $9.82, while CSWYF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, BIOYF's ROE is +0.22%, compared to CSWYF's ROE of +0.12%. Regarding short-term risk, BIOYF is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check CSWYF's competition here
BIOYF vs TRXPF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, BIOYF is priced at $9.82, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, BIOYF's ROE is +0.22%, compared to TRXPF's ROE of +0.03%. Regarding short-term risk, BIOYF is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check TRXPF's competition here
BIOYF vs AGYTF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, AGYTF has a market cap of 655.5M. Regarding current trading prices, BIOYF is priced at $9.82, while AGYTF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas AGYTF's P/E ratio is -13.00. In terms of profitability, BIOYF's ROE is +0.22%, compared to AGYTF's ROE of +2.84%. Regarding short-term risk, BIOYF is more volatile compared to AGYTF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check AGYTF's competition here
BIOYF vs KHTRF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, KHTRF has a market cap of 646M. Regarding current trading prices, BIOYF is priced at $9.82, while KHTRF trades at $6.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas KHTRF's P/E ratio is 164.75. In terms of profitability, BIOYF's ROE is +0.22%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, BIOYF is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check KHTRF's competition here
BIOYF vs YIHCF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, BIOYF is priced at $9.82, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, BIOYF's ROE is +0.22%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, BIOYF is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check YIHCF's competition here
BIOYF vs AIHLF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, BIOYF is priced at $9.82, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, BIOYF's ROE is +0.22%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, BIOYF is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check AIHLF's competition here
BIOYF vs TRSSF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, BIOYF is priced at $9.82, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, BIOYF's ROE is +0.22%, compared to TRSSF's ROE of -0.76%. Regarding short-term risk, BIOYF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check TRSSF's competition here
BIOYF vs BOIRF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, BOIRF has a market cap of 553.9M. Regarding current trading prices, BIOYF is priced at $9.82, while BOIRF trades at $31.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas BOIRF's P/E ratio is 14.63. In terms of profitability, BIOYF's ROE is +0.22%, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, BIOYF is less volatile compared to BOIRF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check BOIRF's competition here
BIOYF vs PKBFF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, BIOYF is priced at $9.82, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas PKBFF's P/E ratio is N/A. In terms of profitability, BIOYF's ROE is +0.22%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, BIOYF is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check PKBFF's competition here
BIOYF vs CCHWF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, BIOYF is priced at $9.82, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, BIOYF's ROE is +0.22%, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, BIOYF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check CCHWF's competition here
BIOYF vs VRNOF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, VRNOF has a market cap of 470.4M. Regarding current trading prices, BIOYF is priced at $9.82, while VRNOF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas VRNOF's P/E ratio is -1.31. In terms of profitability, BIOYF's ROE is +0.22%, compared to VRNOF's ROE of -0.31%. Regarding short-term risk, BIOYF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check VRNOF's competition here
BIOYF vs PEXXF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, BIOYF is priced at $9.82, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, BIOYF's ROE is +0.22%, compared to PEXXF's ROE of N/A. Regarding short-term risk, BIOYF is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check PEXXF's competition here
BIOYF vs SWDCF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, SWDCF has a market cap of 444.4M. Regarding current trading prices, BIOYF is priced at $9.82, while SWDCF trades at $2.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas SWDCF's P/E ratio is 92.67. In terms of profitability, BIOYF's ROE is +0.22%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, BIOYF is more volatile compared to SWDCF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check SWDCF's competition here
BIOYF vs HUMDF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, HUMDF has a market cap of 430.9M. Regarding current trading prices, BIOYF is priced at $9.82, while HUMDF trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas HUMDF's P/E ratio is 2.70. In terms of profitability, BIOYF's ROE is +0.22%, compared to HUMDF's ROE of +1.07%. Regarding short-term risk, BIOYF is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check HUMDF's competition here
BIOYF vs ELTP Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, ELTP has a market cap of 386.9M. Regarding current trading prices, BIOYF is priced at $9.82, while ELTP trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas ELTP's P/E ratio is 8.98. In terms of profitability, BIOYF's ROE is +0.22%, compared to ELTP's ROE of +0.71%. Regarding short-term risk, BIOYF is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check ELTP's competition here
BIOYF vs CRLBF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, CRLBF has a market cap of 322.9M. Regarding current trading prices, BIOYF is priced at $9.82, while CRLBF trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas CRLBF's P/E ratio is -2.40. In terms of profitability, BIOYF's ROE is +0.22%, compared to CRLBF's ROE of -0.35%. Regarding short-term risk, BIOYF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check CRLBF's competition here
BIOYF vs CPHRF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, CPHRF has a market cap of 302.9M. Regarding current trading prices, BIOYF is priced at $9.82, while CPHRF trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas CPHRF's P/E ratio is 10.07. In terms of profitability, BIOYF's ROE is +0.22%, compared to CPHRF's ROE of +0.26%. Regarding short-term risk, BIOYF is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check CPHRF's competition here
BIOYF vs GUERF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, GUERF has a market cap of 281M. Regarding current trading prices, BIOYF is priced at $9.82, while GUERF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas GUERF's P/E ratio is 8.19. In terms of profitability, BIOYF's ROE is +0.22%, compared to GUERF's ROE of +0.04%. Regarding short-term risk, BIOYF is more volatile compared to GUERF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check GUERF's competition here
BIOYF vs BHCCF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, BIOYF is priced at $9.82, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, BIOYF's ROE is +0.22%, compared to BHCCF's ROE of +0.29%. Regarding short-term risk, BIOYF is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check BHCCF's competition here
BIOYF vs NIKA Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, NIKA has a market cap of 209.7M. Regarding current trading prices, BIOYF is priced at $9.82, while NIKA trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas NIKA's P/E ratio is N/A. In terms of profitability, BIOYF's ROE is +0.22%, compared to NIKA's ROE of +0.27%. Regarding short-term risk, BIOYF is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check NIKA's competition here
BIOYF vs PLNHF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, BIOYF is priced at $9.82, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, BIOYF's ROE is +0.22%, compared to PLNHF's ROE of +838111.55%. Regarding short-term risk, BIOYF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check PLNHF's competition here
BIOYF vs CBWTF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, CBWTF has a market cap of 153.4M. Regarding current trading prices, BIOYF is priced at $9.82, while CBWTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas CBWTF's P/E ratio is 10.93. In terms of profitability, BIOYF's ROE is +0.22%, compared to CBWTF's ROE of +0.16%. Regarding short-term risk, BIOYF is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check CBWTF's competition here
BIOYF vs COPHF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, BIOYF is priced at $9.82, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas COPHF's P/E ratio is -0.02. In terms of profitability, BIOYF's ROE is +0.22%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, BIOYF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check COPHF's competition here
BIOYF vs NWPN Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, BIOYF is priced at $9.82, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas NWPN's P/E ratio is -0.04. In terms of profitability, BIOYF's ROE is +0.22%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, BIOYF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check NWPN's competition here
BIOYF vs GRUSF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, GRUSF has a market cap of 115.9M. Regarding current trading prices, BIOYF is priced at $9.82, while GRUSF trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas GRUSF's P/E ratio is 46.36. In terms of profitability, BIOYF's ROE is +0.22%, compared to GRUSF's ROE of +0.01%. Regarding short-term risk, BIOYF is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check GRUSF's competition here
BIOYF vs LOVFF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, LOVFF has a market cap of 113.6M. Regarding current trading prices, BIOYF is priced at $9.82, while LOVFF trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas LOVFF's P/E ratio is 14.38. In terms of profitability, BIOYF's ROE is +0.22%, compared to LOVFF's ROE of +0.09%. Regarding short-term risk, BIOYF is less volatile compared to LOVFF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check LOVFF's competition here
BIOYF vs LPCUF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, LPCUF has a market cap of 112.1M. Regarding current trading prices, BIOYF is priced at $9.82, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas LPCUF's P/E ratio is 9.51. In terms of profitability, BIOYF's ROE is +0.22%, compared to LPCUF's ROE of +0.06%. Regarding short-term risk, BIOYF is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check LPCUF's competition here
BIOYF vs CNVCF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, BIOYF is priced at $9.82, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, BIOYF's ROE is +0.22%, compared to CNVCF's ROE of +1.21%. Regarding short-term risk, BIOYF is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check CNVCF's competition here
BIOYF vs AAWH Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, AAWH has a market cap of 108.8M. Regarding current trading prices, BIOYF is priced at $9.82, while AAWH trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas AAWH's P/E ratio is -0.84. In terms of profitability, BIOYF's ROE is +0.22%, compared to AAWH's ROE of +5.41%. Regarding short-term risk, BIOYF is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check AAWH's competition here
BIOYF vs JUSHF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, JUSHF has a market cap of 103M. Regarding current trading prices, BIOYF is priced at $9.82, while JUSHF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas JUSHF's P/E ratio is -1.43. In terms of profitability, BIOYF's ROE is +0.22%, compared to JUSHF's ROE of +0.66%. Regarding short-term risk, BIOYF is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check JUSHF's competition here
BIOYF vs ORXOF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, ORXOF has a market cap of 101.9M. Regarding current trading prices, BIOYF is priced at $9.82, while ORXOF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas ORXOF's P/E ratio is -2.27. In terms of profitability, BIOYF's ROE is +0.22%, compared to ORXOF's ROE of -2.28%. Regarding short-term risk, BIOYF is more volatile compared to ORXOF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check ORXOF's competition here
BIOYF vs HLTRF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, HLTRF has a market cap of 98.5M. Regarding current trading prices, BIOYF is priced at $9.82, while HLTRF trades at $3.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas HLTRF's P/E ratio is -9.84. In terms of profitability, BIOYF's ROE is +0.22%, compared to HLTRF's ROE of -0.17%. Regarding short-term risk, BIOYF is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check HLTRF's competition here
BIOYF vs MEDXF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, MEDXF has a market cap of 92.8M. Regarding current trading prices, BIOYF is priced at $9.82, while MEDXF trades at $2.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas MEDXF's P/E ratio is -143.60. In terms of profitability, BIOYF's ROE is +0.22%, compared to MEDXF's ROE of -0.01%. Regarding short-term risk, BIOYF is less volatile compared to MEDXF. This indicates potentially lower risk in terms of short-term price fluctuations for BIOYF.Check MEDXF's competition here
BIOYF vs SHIEF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, SHIEF has a market cap of 85.6M. Regarding current trading prices, BIOYF is priced at $9.82, while SHIEF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas SHIEF's P/E ratio is -4.00. In terms of profitability, BIOYF's ROE is +0.22%, compared to SHIEF's ROE of +1.18%. Regarding short-term risk, BIOYF is more volatile compared to SHIEF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check SHIEF's competition here
BIOYF vs ABSCF Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, ABSCF has a market cap of 78.1M. Regarding current trading prices, BIOYF is priced at $9.82, while ABSCF trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas ABSCF's P/E ratio is -37.33. In terms of profitability, BIOYF's ROE is +0.22%, compared to ABSCF's ROE of +0.07%. Regarding short-term risk, BIOYF is more volatile compared to ABSCF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check ABSCF's competition here
BIOYF vs EOFBY Comparison June 2026
BIOYF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOYF stands at 112.3M. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, BIOYF is priced at $9.82, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOYF currently has a P/E ratio of 17.54, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, BIOYF's ROE is +0.22%, compared to EOFBY's ROE of -0.77%. Regarding short-term risk, BIOYF is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for BIOYF.Check EOFBY's competition here